| 940 |
Centers for Disease Control and Prevention |
Html |
en |
HAN Archive - Human Infections with Avian Influenza A (H7N9) Viruses |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| influenza diagnostic test | 0.622272 |
| H7N9 viruses | 0.524108 |
| Influenza diagnostic testing | 0.602133 |
| human influenza | 0.553248 |
| CDC Health Alert | 0.538309 |
| diagnostic test result | 0.533797 |
| avian influenza | 0.939595 |
| influenza-like illness surveillance | 0.588147 |
| United States | 0.535389 |
| novel influenza | 0.613646 |
| avian influenza viruses | 0.610452 |
| human cases | 0.529775 |
| negative rapid influenza | 0.619048 |
| H7N9 cases | 0.525046 |
| acute respiratory infection | 0.563762 |
| local health department | 0.545111 |
| CDC Health Advisory | 0.538121 |
| infection control precautions | 0.60176 |
| influenza virus infection | 0.640256 |
| H7N9 human infections | 0.545723 |
| Severe Human Illness | 0.528141 |
| H7N9 testing | 0.549222 |
| probable cases | 0.500695 |
|
| close contact | 0.55826 |
| CDC avian influenza | 0.677648 |
| virulent influenza viruses | 0.604904 |
| public health | 0.566392 |
| H7N9 infection | 0.596824 |
| influenza A virus | 0.566204 |
| respiratory specimens | 0.534674 |
| national influenza-like illness | 0.511407 |
| cases | 0.532887 |
| World Health Organization | 0.496339 |
| avian influenza virus | 0.663925 |
| patients | 0.538561 |
| widespread mild illness | 0.524247 |
| Monitoring avian influenza | 0.587699 |
| CDC general information | 0.507602 |
| influenza viruses | 0.70155 |
| severe respiratory illness | 0.779653 |
| state public health | 0.554332 |
| appropriate infection control | 0.599021 |
| illness onset | 0.510957 |
| human infection | 0.748635 |
| public health laboratory | 0.556707 |
| infection control guidelines | 0.53177 |
|
CLICK HERE |
| 6383 |
Centers for Disease Control and Prevention |
Html |
en |
Young adults' perceptions of cigarette warning labels in the United States and Canada. |
null |
| study participants | 0.419239 |
| Canadian cigarette labels | 0.476748 |
| young adult smokers | 0.438533 |
| Linda L. Pederson | 0.423221 |
| focus group sessions | 0.460651 |
| current smokers | 0.426061 |
| text-only cigarette | 0.419572 |
| Canadian cigarette label | 0.490939 |
| U.S. cigarette | 0.63168 |
| white warning text | 0.434383 |
| Smoking This Cigarette | 0.437441 |
| tobacco warning labels | 0.448534 |
| cigarette warning messages | 0.496972 |
| recent graduate group | 0.70001 |
| cigarette warning labels | 0.995019 |
| decrease cigarette consumption | 0.463972 |
| young adults | 0.428923 |
| cigarette package warnings | 0.427929 |
| Canadian cigarette | 0.678416 |
| large graphic warning | 0.44921 |
| Canadian warning labels | 0.501572 |
| United States | 0.492426 |
| warning label size | 0.422902 |
| new warning labels | 0.468332 |
| smokers | 0.596533 |
|
| current U.S. cigarette | 0.45636 |
| health warning labels | 0.516098 |
| focus groups | 0.579918 |
| smoking | 0.551118 |
| U.S. cigarette packages | 0.490447 |
| smoking health hazards | 0.415699 |
| participants | 0.634324 |
| graphic warning labels | 0.55515 |
| U.S. cigarette package | 0.444859 |
| cigarette label health | 0.443923 |
| Federal Cigarette Labeling | 0.431866 |
| Detroit metropolitan area | 0.440059 |
| focus group participants | 0.494572 |
| Cigarette smoking | 0.452863 |
| Canadian cigarette packages | 0.443048 |
| listing cigarette ingredients | 0.424224 |
| text-only warning labels | 0.468541 |
| explicit graphic warning | 0.435086 |
| cigarette packages | 0.859014 |
| focus group | 0.556838 |
| U.S. warning labels | 0.517667 |
| health risks | 0.415369 |
| various cigarette brands | 0.415376 |
| cigarette label text | 0.451249 |
|
CLICK HERE |
| 6404 |
Centers for Disease Control and Prevention |
Html |
en |
National Diabetes Month - November 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.556902 |
| CDC | 0.623044 |
| Human Services | 0.756231 |
| control programs | 0.546142 |
| assistive technology | 0.558813 |
| Fowler SE | 0.531766 |
| type | 0.537739 |
| Engl J Med | 0.54924 |
| MMWR HTML versions | 0.640434 |
| U.S. Department | 0.622474 |
| Native Diabetes Wellness | 0.903234 |
| private partners | 0.54255 |
| National Diabetes Prevention | 0.925594 |
| fact sheet | 0.5366 |
| electronic PDF version | 0.629816 |
| Contact GPO | 0.553548 |
| National Diabetes | 0.931955 |
| weight loss | 0.543826 |
| yearly influenza vaccine | 0.646165 |
| commercial sources | 0.531632 |
| cooperative agreements | 0.536754 |
| current prices | 0.528638 |
| national estimates | 0.542594 |
| diabetes control | 0.791157 |
|
| original paper copy | 0.635366 |
| Knowler WC | 0.556918 |
| new cases | 0.542193 |
| general information | 0.539698 |
| United States | 0.676321 |
| U.S. Government Printing | 0.641992 |
| original MMWR paper | 0.636375 |
| kidney failure | 0.537489 |
| nontraumatic lower-limb amputations | 0.679132 |
| MMWR readers | 0.537339 |
| character translation | 0.525945 |
| territorial diabetes prevention | 0.924304 |
| Alaska Native communities | 0.656711 |
| CDC. National | 0.544263 |
| format errors | 0.525489 |
| subject line | 0.555907 |
| evidence-based lifestyle interventions | 0.652921 |
| typeset documents | 0.531994 |
| trade names | 0.531718 |
| official text | 0.524584 |
| physical activity | 0.676766 |
| non-CDC sites | 0.530403 |
| traditional local foods | 0.65641 |
| et al | 0.528805 |
|
CLICK HERE |
| 6418 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, November 28, 2011 |
null |
| endorsement | 0.373865 |
| current awareness | 0.389405 |
| findings | 0.332799 |
| asterisk | 0.322815 |
| full-text link | 0.3949 |
| New York City | 0.47006 |
| Continuum | 0.319012 |
| Disease Control | 0.389874 |
| CDC Science Clips | 0.757135 |
| clinicians | 0.317304 |
| HIV-related medical care | 0.47991 |
| factual accuracy | 0.390512 |
| issue | 0.337804 |
| Chief Science Officer | 0.488124 |
| conclusions | 0.317063 |
| scientific articles | 0.416294 |
| care stay | 0.392647 |
| DHHS | 0.418476 |
| regular format | 0.399974 |
| DISCLAIMER | 0.320282 |
| proofs | 0.317651 |
| general review articles | 0.49422 |
| public domain | 0.397676 |
| CDC licensed materials | 0.615393 |
| Stephen B. Thacker | 0.656897 |
|
| current Vital Signs | 0.494678 |
| items | 0.343133 |
| SFX window | 0.406276 |
| authoritative sources | 0.404175 |
| www.cdc.gov/vitalsigns | 0.318016 |
| public health professionals | 0.482842 |
| scientific information | 0.398639 |
| omission | 0.322308 |
| views | 0.330372 |
| weekly digest | 0.407865 |
| Science Clips | 0.955797 |
| informational purposes | 0.384514 |
| public health literature | 0.46454 |
| SFX server | 0.406954 |
| permission | 0.317459 |
| B. Thacker CDC | 0.791249 |
| background information | 0.399142 |
| original authors | 0.390076 |
| opinion | 0.326535 |
| non-CDC Websites | 0.39 |
| original sources | 0.397213 |
| Vol. | 0.3194 |
| CDC Vital Signs | 0.659984 |
| news sources | 0.391432 |
|
CLICK HERE |
| 6717 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria Surveillance - United States, 2010 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| reported malaria cases | 0.333089 |
| CDC | 0.262625 |
| malaria chemoprophylaxis | 0.35775 |
| P. malariae | 0.275702 |
| falciparum cerebral malaria | 0.25523 |
| Uncomplicated Imported Malaria | 0.239477 |
| antimalarial drugs | 0.259148 |
| appropriate malaria prevention | 0.257876 |
| P. falciparum | 0.745527 |
| state health departments | 0.243788 |
| malaria infection | 0.278485 |
| additional malaria cases | 0.263008 |
| P. falciparum infection | 0.279317 |
| malaria prevention strategies | 0.275881 |
| ongoing malaria transmission | 0.255122 |
| patients | 0.330478 |
| malaria chemoprophylaxis regimen | 0.251661 |
| Malaria Hotline | 0.246232 |
| emergency department | 0.240225 |
| National Malaria Surveillance | 0.285574 |
| renal failure | 0.262827 |
| malaria infections | 0.263298 |
| P. ovale | 0.286505 |
| CDC malaria staff | 0.25909 |
| uncomplicated malaria infections | 0.235775 |
|
| malaria case surveillance | 0.252939 |
| severe malaria | 0.352133 |
| United States | 0.896772 |
| Malaria vector mosquitoes | 0.242489 |
| malaria | 0.930646 |
| P. vivax | 0.426537 |
| malaria acquisition | 0.236894 |
| effective malaria prevention | 0.258043 |
| P. falciparum cases | 0.252122 |
| malaria symptoms | 0.234463 |
| falciparum severe malaria | 0.263201 |
| CDC-recommended malaria chemoprophylaxis | 0.246437 |
| uncomplicated malaria | 0.239743 |
| falciparum malaria infection | 0.257488 |
| imported malaria cases | 0.321949 |
| malaria prevention recommendations | 0.286299 |
| cases | 0.784194 |
| P. falciparum malaria | 0.345406 |
| Malaria treatment recommendations | 0.26176 |
| malaria cases | 0.484539 |
| malaria prevention | 0.328149 |
| species | 0.236687 |
| malaria transmission | 0.288045 |
| malaria surveillance | 0.32306 |
|
CLICK HERE |
| 8916 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Information Statement: Chickenpox - Vaccines - CDC |
Chickenpox Vaccine Information Statement |
| Compensation Program | 0.351848 |
| blood products | 0.355103 |
| individual vaccines | 0.366195 |
| Page | 0.392412 |
| National Vaccine Injury | 0.499549 |
| severe skin infection | 0.431303 |
| nearest hospital | 0.352116 |
| severe allergic reaction | 0.570558 |
| Mild rash | 0.373353 |
| fast heartbeat | 0.352919 |
| chickenpox vaccine | 0.983305 |
| chickenpox vaccination | 0.53644 |
| chickenpox blisters | 0.582459 |
| severe brain reactions | 0.410445 |
| Vaccine Adverse Event | 0.491699 |
| Mild problems | 0.362256 |
| brain damage | 0.360477 |
| behavior changes | 0.352611 |
| varicella vaccines | 0.363893 |
| VAERS website | 0.360718 |
| life-threatening allergic reaction | 0.420235 |
| dose | 0.408991 |
| Pregnant women | 0.354224 |
| common childhood disease | 0.414837 |
|
| person | 0.408155 |
| previous dose | 0.37756 |
| difficulty breathing | 0.350449 |
| higher rates | 0.351705 |
| United States | 0.411585 |
| painful rash | 0.380294 |
| fever | 0.37824 |
| Severe problems | 0.370676 |
| medical advice | 0.353925 |
| fewer blisters | 0.364021 |
| MMRV vaccine | 0.453417 |
| state health department | 0.396284 |
| Current Edition Date | 0.419214 |
| young infants | 0.36599 |
| chickenpox virus | 0.578975 |
| MMR vaccines | 0.370204 |
| severe allergic reactions | 0.426292 |
| people | 0.447389 |
| certain vaccines | 0.359437 |
| doctor | 0.371462 |
| federal program | 0.351805 |
| chickenpox disease | 0.541772 |
| antibiotic neomycin | 0.360483 |
| Moderate problems | 0.357296 |
|
CLICK HERE |
| 9423 |
Centers for Disease Control and Prevention |
Html |
es |
El abordaje integral de las necesidades de los niños: qué puede hacer la salud pública en respuesta al llamado del sector educativo para crear una alianza más fuerte |
null |
| salud pública | 0.976366 |
| Katz S | 0.34838 |
| Estados Unidos | 0.405992 |
|
| Lewallen TC | 0.351407 |
| Chronic Dis | 0.349896 |
|
CLICK HERE |
| 10130 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Global Health Security - Prevent |
null |
| endorsement | 0.282622 |
| CDC | 0.261195 |
| institutional factors | 0.552576 |
| supply chains | 0.540718 |
| Promote safe practices | 0.767667 |
| minimal number | 0.510735 |
| responsible conduct | 0.498205 |
| infection control | 0.494301 |
| effort | 0.25287 |
| epidemic-prone diseases | 0.481205 |
| research | 0.250211 |
| Content source | 0.508551 |
| HHS | 0.289022 |
| ways | 0.250539 |
| Notice | 0.25823 |
| novel zoonotic diseases | 0.881873 |
| antimicrobial resistance | 0.591719 |
| dangerous microbes | 0.569856 |
| early detection | 0.526106 |
| animals | 0.307619 |
| surveillance | 0.255805 |
|
| drug-resistant microorganisms | 0.608341 |
| disease threats | 0.563113 |
| settings | 0.256009 |
| development | 0.250599 |
| emergence | 0.278559 |
| strategies | 0.251283 |
| livestock production | 0.518466 |
| diagnosis | 0.250271 |
| biosurveillance | 0.250122 |
| countries | 0.250479 |
| food safety | 0.509984 |
| biological materials | 0.505122 |
| marketing | 0.252275 |
| non-federal site | 0.535025 |
| zoonotic diseases | 0.951589 |
| safely monitoring | 0.515269 |
| effective programs | 0.48883 |
| facilities | 0.249061 |
| employees | 0.248225 |
| antibiotics | 0.275006 |
| humans | 0.262839 |
|
CLICK HERE |
| 10959 |
Centers for Disease Control and Prevention |
Html |
en |
Decoding MERS Coronavirus: AMD provides quick answers |
To decode the 2014 Middle East Respiratory Syndrome (MERS-CoV), CDC used advanced molecular detection (AMD) methods. |
| CDC | 0.784477 |
| new sequence information | 0.565427 |
| traveler | 0.234564 |
| nation | 0.232614 |
| rapid pace | 0.379031 |
| Respiratory Syndrome Coronavirus | 0.600642 |
| public health investigators | 0.812259 |
| funded work | 0.408066 |
| emergent threats | 0.393171 |
| far-reaching effort | 0.428435 |
| number | 0.23306 |
| lower airways | 0.399334 |
| serum specimen | 0.444247 |
| AMD | 0.540147 |
| stronger safeguards | 0.409148 |
| case | 0.269333 |
| infectious disease outbreaks | 0.594276 |
| Indiana State Department | 0.575975 |
| additional sputum | 0.402224 |
| mucus | 0.256356 |
| timeliness | 0.245394 |
| person | 0.255206 |
| East Respiratory Syndrome | 0.954251 |
| positive result | 0.420351 |
| Action | 0.235846 |
|
| United States | 0.596467 |
| AMD methods | 0.477474 |
| Advanced Molecular Detection | 0.562293 |
| scientific community | 0.387478 |
| significant changes | 0.38065 |
| bioinformatics capabilities | 0.424276 |
| parallel work | 0.377288 |
| Saudi Arabia | 0.626885 |
| Major changes | 0.391272 |
| complete virus genome | 0.62684 |
| patient | 0.269213 |
| genetic sequencing methods | 0.648119 |
| Middle East Respiratory | 0.954449 |
| cases | 0.233042 |
| infectious disease outbreak | 0.621648 |
| unknown agents | 0.386162 |
| positive laboratory result | 0.592779 |
| GenBank | 0.242779 |
| AMD funding | 0.527522 |
| significant leap | 0.43059 |
| infectious disease | 0.623945 |
| AMD program | 0.53947 |
| responses | 0.235918 |
| MERS-CoV sequences | 0.382228 |
|
CLICK HERE |
| 13899 |
Centers for Disease Control and Prevention |
Html |
en |
Final Cumulative Maps & Data for 1999-2014 | West Nile Virus | CDC |
Information on West Nile Virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| North Carolina | 0.87528 |
| Vermont | 0.57611 |
| Puerto Rico | 0.938142 |
| Indiana | 0.583067 |
| Maine | 0.581301 |
| Tennessee | 0.577166 |
| Dist. | 0.586532 |
| Alabama | 0.593276 |
| Arkansas | 0.592172 |
| South Carolina | 0.867726 |
| Utah | 0.576461 |
| Washington | 0.575407 |
| Nebraska | 0.578494 |
| West Virginia | 0.908651 |
| Colorado | 0.591438 |
| Massachusetts | 0.580597 |
| Missouri | 0.579194 |
| Alaska | 0.592908 |
| North Dakota | 0.874321 |
| Arizona | 0.59254 |
| Nevada | 0.578144 |
| Rhode Island | 0.938849 |
| New York | 0.879197 |
|
| Montana | 0.578844 |
| Kentucky | 0.582007 |
| South Dakota | 0.866775 |
| Hawaii | 0.584131 |
| Minnesota | 0.579895 |
| California | 0.591805 |
| Kansas | 0.58236 |
| Delaware | 0.590705 |
| Florida | 0.589955 |
| New Jersey | 0.881132 |
| Michigan | 0.580246 |
| Iowa | 0.582713 |
| Mississippi | 0.579544 |
| Columbia | 0.586514 |
| New Mexico | 0.890167 |
| Illinois | 0.583421 |
| Texas | 0.576814 |
| New Hampshire | 0.892145 |
| Connecticut | 0.591071 |
| Louisiana | 0.581654 |
| Ohio | 0.575656 |
| Georgia | 0.58959 |
| Maryland | 0.580949 |
|
CLICK HERE |